EP3994277A1 - Verfahren und testkit zur bisulfitmodifizierung von dna - Google Patents
Verfahren und testkit zur bisulfitmodifizierung von dnaInfo
- Publication number
- EP3994277A1 EP3994277A1 EP20750595.9A EP20750595A EP3994277A1 EP 3994277 A1 EP3994277 A1 EP 3994277A1 EP 20750595 A EP20750595 A EP 20750595A EP 3994277 A1 EP3994277 A1 EP 3994277A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- dna
- bisulfite
- solid phase
- buffer
- rough surface
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 title claims abstract description 114
- 238000000034 method Methods 0.000 title claims abstract description 67
- 238000012360 testing method Methods 0.000 title claims abstract description 7
- 230000004048 modification Effects 0.000 title abstract description 52
- 238000012986 modification Methods 0.000 title abstract description 52
- 239000007790 solid phase Substances 0.000 claims abstract description 31
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 18
- 239000011707 mineral Substances 0.000 claims abstract description 18
- 229920003023 plastic Polymers 0.000 claims description 40
- 239000004033 plastic Substances 0.000 claims description 40
- 238000005406 washing Methods 0.000 claims description 25
- 239000000872 buffer Substances 0.000 claims description 22
- 229920000426 Microplastic Polymers 0.000 claims description 21
- 239000000243 solution Substances 0.000 claims description 21
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 claims description 19
- 239000008187 granular material Substances 0.000 claims description 18
- 238000011534 incubation Methods 0.000 claims description 16
- 238000005869 desulfonation reaction Methods 0.000 claims description 14
- 108020004707 nucleic acids Proteins 0.000 claims description 14
- 150000007523 nucleic acids Chemical class 0.000 claims description 14
- 102000039446 nucleic acids Human genes 0.000 claims description 14
- 239000011541 reaction mixture Substances 0.000 claims description 13
- 230000006326 desulfonation Effects 0.000 claims description 12
- 239000011534 wash buffer Substances 0.000 claims description 12
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 claims description 8
- 229940104302 cytosine Drugs 0.000 claims description 8
- 239000006228 supernatant Substances 0.000 claims description 8
- 230000005298 paramagnetic effect Effects 0.000 claims description 7
- 239000012148 binding buffer Substances 0.000 claims description 4
- 229940035893 uracil Drugs 0.000 claims description 4
- 238000001035 drying Methods 0.000 claims description 3
- 239000002184 metal Substances 0.000 claims description 3
- 229910052751 metal Inorganic materials 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 239000005060 rubber Substances 0.000 claims description 2
- 239000012071 phase Substances 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 abstract description 42
- 239000000463 material Substances 0.000 abstract description 35
- 238000006481 deamination reaction Methods 0.000 abstract description 8
- 230000011987 methylation Effects 0.000 abstract description 6
- 238000007069 methylation reaction Methods 0.000 abstract description 6
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 abstract description 4
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 abstract description 4
- ZETCGWYACBNPIH-UHFFFAOYSA-N azane;sulfurous acid Chemical compound N.OS(O)=O ZETCGWYACBNPIH-UHFFFAOYSA-N 0.000 abstract 1
- 239000004289 sodium hydrogen sulphite Substances 0.000 abstract 1
- 108020004414 DNA Proteins 0.000 description 134
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 39
- 238000003753 real-time PCR Methods 0.000 description 35
- 238000003556 assay Methods 0.000 description 34
- 239000000523 sample Substances 0.000 description 31
- 238000006011 modification reaction Methods 0.000 description 22
- 230000003321 amplification Effects 0.000 description 21
- 238000003199 nucleic acid amplification method Methods 0.000 description 21
- 239000003153 chemical reaction reagent Substances 0.000 description 19
- 210000001520 comb Anatomy 0.000 description 17
- 230000027455 binding Effects 0.000 description 14
- 230000008569 process Effects 0.000 description 14
- 238000000605 extraction Methods 0.000 description 12
- 239000011521 glass Substances 0.000 description 12
- 239000006249 magnetic particle Substances 0.000 description 10
- 238000011529 RT qPCR Methods 0.000 description 9
- 238000013459 approach Methods 0.000 description 9
- 238000004925 denaturation Methods 0.000 description 9
- 230000036425 denaturation Effects 0.000 description 9
- 239000012149 elution buffer Substances 0.000 description 8
- 230000005291 magnetic effect Effects 0.000 description 8
- 230000001476 alcoholic effect Effects 0.000 description 7
- 239000002245 particle Substances 0.000 description 7
- 108090000623 proteins and genes Proteins 0.000 description 7
- 241001504639 Alcedo atthis Species 0.000 description 6
- 108091029430 CpG site Proteins 0.000 description 6
- 101000756632 Homo sapiens Actin, cytoplasmic 1 Proteins 0.000 description 6
- 238000010584 magnetic trap Methods 0.000 description 6
- 230000007067 DNA methylation Effects 0.000 description 5
- 238000012545 processing Methods 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 108091028043 Nucleic acid sequence Proteins 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 230000009615 deamination Effects 0.000 description 4
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical class CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 4
- 102100022900 Actin, cytoplasmic 1 Human genes 0.000 description 3
- 108010085238 Actins Proteins 0.000 description 3
- 108091029523 CpG island Proteins 0.000 description 3
- 108091081021 Sense strand Proteins 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000000692 anti-sense effect Effects 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- AOSFMYBATFLTAQ-UHFFFAOYSA-N 1-amino-3-(benzimidazol-1-yl)propan-2-ol Chemical compound C1=CC=C2N(CC(O)CN)C=NC2=C1 AOSFMYBATFLTAQ-UHFFFAOYSA-N 0.000 description 2
- PKVZBNCYEICAQP-UHFFFAOYSA-N Mecamylamine hydrochloride Chemical compound Cl.C1CC2C(C)(C)C(NC)(C)C1C2 PKVZBNCYEICAQP-UHFFFAOYSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000013065 commercial product Substances 0.000 description 2
- 230000001973 epigenetic effect Effects 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 230000006607 hypermethylation Effects 0.000 description 2
- 210000003463 organelle Anatomy 0.000 description 2
- 239000002516 radical scavenger Substances 0.000 description 2
- 230000009870 specific binding Effects 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 208000005623 Carcinogenesis Diseases 0.000 description 1
- 241000579894 Chloroceryle americana Species 0.000 description 1
- 208000037051 Chromosomal Instability Diseases 0.000 description 1
- 238000007400 DNA extraction Methods 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- 229940123457 Free radical scavenger Drugs 0.000 description 1
- 208000026350 Inborn Genetic disease Diseases 0.000 description 1
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 238000002123 RNA extraction Methods 0.000 description 1
- 108091061939 Selfish DNA Proteins 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- 210000001766 X chromosome Anatomy 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 238000010170 biological method Methods 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000012733 comparative method Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000006477 desulfuration reaction Methods 0.000 description 1
- 230000023556 desulfurization Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007608 epigenetic mechanism Effects 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 208000016361 genetic disease Diseases 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 238000007885 magnetic separation Methods 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000004005 microsphere Substances 0.000 description 1
- 229910052755 nonmetal Inorganic materials 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- -1 polypropylene Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 229940113082 thymine Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
Definitions
- the present application relates to a method and a test kit for carrying out a reaction for bisulfite modification of DNA to determine the
- Methylation pattern of the DNA characterized in that after
- the modified DNA is bound to a rough solid phase and all further necessary process steps are carried out on this rough solid phase. Finally, the modified, highly pure DNA is detached from this solid phase.
- the method can be carried out manually or automatically.
- the rough solid phase is a non-mineral material with a rough surface.
- a rough surface is understood to be a non-smooth or structured surface of a material that is preferably made of metal, plastic or rubber.
- Cavity produce a structure which functions as a non-smooth surface and can therefore also be used according to the invention.
- DNA methylation is an epigenetic mechanism that occurs in most
- Organisms is found. Its main functions in prokaryotes are aimed at protecting against parasitic DNA and controlling the accuracy of replication. In
- the predominant methylation site is the 5-carbon of cytosine within the CpG dinucleotide sites. More than half of the genes contain short ( ⁇ 1 kb) CpG-rich regions called CpG islands, while the rest of the genome has no CpGs. While CpG sites in CpG islands are predominantly unmethylated, most CpG sites outside of CpG islands are normally methylated. The elucidation of the function of CpG methylation has proven difficult and appears to vary with context. The CpG methylation is on several genes.
- hypomethylation while several specific genes are methylated (gene-specific hypermethylation). Hypomethylation typically affects repetitive elements of DNA, while hypermethylation usually occurs within CpG islets. nowadays DNA methylation analysis has become an important tool for studying cancer, gene expression, genetic diseases, and many other important aspects of biology. The study of DNA methylation is also in the
- the prior art also includes the document WO 2004/053115 A1.
- This describes a method and kit for isolating a target cell, a cell organelle or a virus from a sample, using, inter alia, a non-specific or little specific binding between a target cell, a cell organelle or a virus with a magnetic microsphere.
- the object of the invention was to eliminate the disadvantages of the solutions described in the prior art.
- the aim of the present invention was to provide a
- the present invention achieves these objects in all of the points defined.
- the essence of the invention is the knowledge that free nucleic acids or nucleic acids released by lysis can be bound to a solid phase with a rough surface under specific binding conditions, where they are washed and finally eluted from this rough surface.
- the term "rough surface” is to be understood as meaning that by touching the
- Non-mineral solid phases in the sense of this
- Invention are materials that do not consist of glass, silicon dioxide, an ion exchanger or hydroxyapatite.
- An arrangement of per se non-rough materials in a cavity can also lead to the creation of a “rough” or structured surface due to corners or edges being formed.
- rough surface is to be understood in such a way that by touching or looking at the surface it can be seen that it is not smooth. However, it can also be a surface that has a structure (e.g. grooves). This structure removes the smoothness of the surface, even if the structure, i.e. the grooves, itself can be smooth. According to the invention, such surfaces are referred to as “structured surfaces”. If it is not possible to tell whether a surface is smooth or rough by looking at or touching the surface, a test can be carried out in which a laser beam is aimed at that surface. If the surface is smooth, the laser will only work in
- the process can be carried out both manually and automatically.
- automated bisulfite modification of DNA there are currently no suitable solutions.
- the manual method according to the invention for bisulfite modification of DNA is carried out in a preferred variant as follows.
- Materials for binding the DNA are plastic granules with a rough surface, which are preferably paramagnetic.
- plastic granulates, the surface of which has been mechanically roughened are placed in a 2.0 ml reaction vessel for this purpose.
- the bisulfite modification reaction (deamination and / or desulfonation step as well as necessary washing steps) are carried out with reagents from a commercially available kit for bisulfite modification of DNA (innuCONVERT Bisulfite Basic Kit; Analytik Jena AG).
- the reaction mixture is transferred to the 2.0 ml reaction vessel with the granules.
- the binding of the DNA to the surface of the rough plastic granulate is initiated by adding a binding buffer, which contains an alcoholic component and other additives, or by adding just one alcohol. After a short incubation, the supernatant is removed from the plastic granulate by placing the reaction vessel in a magnetic trap.
- the bound modified DNA is washed with an alcoholic washing buffer
- a desulfonation buffer is added to the reaction vessel with the granulate
- the modified DNA is finalized by adding a low salt buffer from
- Granules according to the invention detached.
- Bisulfite reagent all process steps necessary for a bisulfite modification of DNA are of the kind that none of the previously used mineral
- the means and method according to the invention also reveal further advantages. For the processing of larger sample volumes, it is necessary to parallelize processes and, in the most effective case, to automate them. With regard to the process of bisulfite modification of DNA, there are a large number of commercially available products for manual processing, but very few products for processing large sample sizes. Automated solutions cannot be found commercially and must be implemented individually by users on automation platforms.
- the agent according to the invention is ideally suited to carry out an automated bisulfite modification of DNA.
- the material with the rough surface is located within a pipette tip, so that reagents can flow past this material.
- the same material that was used for manual bisulfite modification can also be placed in a pipette tip.
- the method according to the invention runs in the form of a "walk-away process" as follows:
- the pipette tip according to the invention is empty. 5.
- the desulphonation reaction of the DNA bound to the plastic granulate then takes place inside the pipette tip. This is done by pipetting up and down a desulfonation buffer (innuCONVERT Bisulfite Basic Kit; Analytik Jena AG).
- Rough materials can be used, modified plastic materials whose surfaces are not smooth but structured. This also includes so-called composite materials, which are mixtures of polymers and, for example, organic components or metallic components. It is only essential to provide a roughened or structured surface (not a smooth
- the architecture of the plastic material is also not limiting (round, rectangular, etc.). It is only important that the material can be brought into a pipette tip and also remains in this position and that a liquid can be washed around it at any time without the liquid having to pass through the material introduced.
- a pipette tip can also be used in which there is (from an injection molded part manufactured) that the binding material is already in place and no longer has to be brought into the tip.
- a device platform that is a commercially available magnetic particle processor (e.g. KingFisher Flex for DNA / RNA extraction and processing of 96 samples) is used and misappropriated.
- a commercially available magnetic particle processor e.g. KingFisher Flex for DNA / RNA extraction and processing of 96 samples
- the device uses plastic combs into which magnetic bars move, which then move magnetic particles in a walk-away process and immerse them in the buffers required for a standard extraction. These plastic combs were used for the method according to the invention for purposes other than those intended by their lower end being mechanically roughened. The method according to the invention for bisulfite modification of DNA was then implemented automatically by means of the device. In contrast to the
- the pipette tip variant binds the DNA to the rough surface of the plastic combs and goes through all the necessary steps following the initial deamination reaction in a walk-away workflow.
- the procedure is extremely simple and allows up to 96 samples to be processed in parallel.
- the present invention thus ideally enables the implementation of the objective already mentioned.
- the method of bisulfite modification of DNA including all the necessary process steps does not require any mineral materials known from the prior art, but only roughened surfaces.
- the automated bisulfite modification was carried out with the InnuPure C16 automatic extraction device (Analytik Jena AG). This automatic extraction system is based on a magnetic particle nucleic acid extraction, but was used for the process “for a different purpose” without magnetic particles.
- Cavity 4 1 ml Washing Solution LS (Analytik Jena AG)
- the reaction mixture of the cavity 1 was carried out by means of the
- the DNA bound to the rough plastic granules was brought into contact with desulfonation buffer (4 times AuF and pipetting off). An incubation time of 2 minutes with Desulfonation Buffer was observed for each pipetting step.
- the DNA bound to the plastic granules was then washed successively in three additional cavities containing alcoholic washing buffers (Washing Solution LS, 80% ethanol, 80% ethanol) by pipetting in and out.
- alcoholic washing buffers Wash Solution LS, 80% ethanol, 80% ethanol
- the tip according to the invention and the rough plastic granules contained in it were dried by pipetting air in and out 60 times and the remaining ethanol was thus removed.
- the nucleic acids were eluted by pipetting the AuF 150 times and pipetting off with 100 ml elution buffer which had previously been tempered to 50 ° C. by the device.
- the total volume of elution BuFfer was 100 m3.
- Automatic extraction machines can be used for carrying out the method according to the invention with the agent according to the invention corresponding thereto.
- the time required compared to a spin column-based extraction is less.
- a real-time PCR assay specific for the actin beta gene locus was used to quantify the total amount of bisulfite-modified DNA.
- the Actin Beta gene locus does not contain any CpG sites, therefore, after the bisulfite modification reaction, all cytosines from this gene locus are converted into uracils and these are detected as thymines in a real-time PCR assay. This assay was used to verify that the genomic DNA is bisulfite modified.
- Taq-man probe 5 '-F AM- ACC ACC ACCC AACACAC AAT AACAAAC ACA-BHQ- 1 -3'
- Reverse primer 50 pmol / m ⁇ : 0.1 m ⁇
- Taq-man probe (25 pmol / m ⁇ ): 0.1 m ⁇
- the real-time PCR was carried out in the CFX96 real-time system by the company Biorad.
- Step 1 Denaturation 95 ° C / 120 "
- Step 2 amplification 40 cycles (95 ° C / 4 "; 57 ° C / 40")
- FIG. 1 shows a real-time PCR from the ⁇ -actin assay.
- gray curves genomic DNA
- magenta curves no template control
- blue and green curve samples DNA after the respective bisulfite modification reaction.
- the cytosine free flagment (CFF-1) assay amplifies genomic and bisulfite-modified DNA with the same efficiency and is therefore suitable for quantifying the yield of bisulfite-modified DNA. It enables the direct comparison of input DNA and output DNA of the bisulite modification reaction.
- genomic DNA the sense and the antisence strand serve as templates.
- the antisense strand serves as a template in bisulfite-modified DNA, because the antisense strand (contains cytosines) is not available for the amplification reaction after the bisulfite modification.
- Primem and Taq-man probe are as follows. Forward primer: 5 '-T AAG AGT AAT AATGGATGG ATG ATG-3'
- Taq-man probe 5'- F AM- ATGGATG AAGAAAGAAAGGATG AGT-BHQ- 1 -3 'Real-Time PCR approach:
- the real-time PCR was carried out in the CFX96 real-time system by Biorad: Amplification conditions:
- Step 1 Denaturation 95 ° C / 120 "
- Step 2 amplification 40 cycles (95 ° C / 4 "; 52 ° C / 40")
- FIG. 2 shows a real-time PCR from the CFF-1 assay. (magenta curves: No.
- Reverse primer 50 pmol / m ⁇ : 0.1 m ⁇
- Step 1 Denaturation 95 ° C / 120 "
- Step 2 Amplification 40 cycles (95 ° C / 4 "; 58 ° C / 40")
- FIG. 3 shows a real-time PCR of the CFP 415 bp assay. (magenta curves: No Template Control, green and blue curves: samples DNA after
- the automated purification was done with the magnetic particle processor
- Plastic combs into which magnetic rods penetrate and which then move magnetic particles in a walk-away process which are used to isolate nucleic acids. These plastic combs were used outside of their normal intended use to carry out the fiction, contemporary method.
- the plastic material of the combs is polypropylene. According to the invention, the plastic combs were roughened using a grinding machine.
- the reagents used for bisulfite modification of the nucleic acids were partly taken from the commercial kit “innuCONVERT Bisulfite Basic Kit”; Analytik Jena AG, taken. For the bisulfite modification 5 gg of genomic DNA with 70 m ⁇ conversion
- Deep well plate 2 1 ml Washing Solution HS (Analytik Jena AG)
- Deep well plate 3 1 ml desulfonation buffer (innuCONVERT Bisulfite Basic Kit; Analytik Jena AG)
- Deep well plate 4 1 ml Washing Solution LS (Analytik Jena AG)
- Deep well plate 7 100 ml Elution Buffer (innuCONVERT Bisulfite Basic Kit; Analytik Jena AG)
- the reaction mixture described above was after the incubation in the cavity 1 given, which was filled with 250 m ⁇ 99.8% ethanol. A further 5 ml Binding Optimizer (Analytik Jena AG) were added to this reaction mixture. The automated process was then carried out on the KingFisher Flex machine.
- the reaction mixture of cavity 1 was mixed by means of the rough plastic combs according to the invention by repeating vertical movements (moving in and out within the deep well plate cavity).
- the bisulfite-modified DNA binds to the rough plastic surface of the plastic combs.
- After binding of the DNA it was washed by vertical movement of the comb in the cavity of the deep well plate 2 with the Washing Solution HS (Analytik Jena AG) contained therein
- the rough plastic combs were slowly moved vertically up and down in desulfonation buffer for 8 minutes.
- the bisulfite-modified DNA bound to the rough plastic combs was then successively transferred to three further deep-well plates containing alcoholic washing buffers (Washing Solution FS, 80% ethanol, 80% ethanol), each for 30 seconds washed slowly moving up and down vertically.
- alcoholic washing buffers Wash Solution FS, 80% ethanol, 80% ethanol
- the plastic combs were dried on the foot for 10 minutes and the remaining ethanol was removed.
- the bisulfite-modified DNA was eluted from the rough plastic combs by moving the plastic combs vertically for 10 minutes in elution buffer, which had previously been heated to 80 ° C. by the device.
- the total volume of elution buffer was 100 ml.
- the method is extremely simple and fast and shows that with the commercially available automatic extraction KingFisher Flex an automated bisulfite modification of up to 96 sample DNAs can be carried out in parallel by modifying the plastic combs alone.
- the modified DNA was again analyzed using various real-time PCR assays.
- a real-time PCR assay specific for the actin beta gene locus was used to quantify the total amount of bisulfite-modified DNA.
- the Actin Beta gene locus does not contain any CpG sites, so all cytosines from this gene locus are converted into uracils after the bisulfite modification reaction and these are detected as thymine in a real-time PCR assay. This assay was used to check whether the genomic DNA was bisulfite-modified.
- Taq-man probe 5 '-F AM- ACC ACC ACCC AACACAC AAT AACAAAC ACA-BHQ- 1 -3'
- Reverse primer 50 pmol / m ⁇ : 0.1 m ⁇
- Taq-man probe (25 pmol / m ⁇ ): 0.1 m ⁇
- the real-time PCR was carried out in the CFX96 real-time system from Biorad.
- Step 1 Denaturation 95 ° C / 120 "
- Step 2 amplification 40 cycles (95 ° C / 4 "; 57 ° C / 40")
- FIG. 4 shows a real-time PCR from the ⁇ -actin assay.
- gray curves genomic DNA
- magenta curves no template control
- blue and green curve samples DNA after the respective bisulfite modification reaction.
- the cytosine free fragment (CFF-1) assay amplifies genomic and bisulfite-modified DNA with the same efficiency and is therefore suitable for quantifying the yield of bisulfite-modified DNA. It enables the direct comparison of input DNA and output DNA of the bisulite modification reaction.
- genomic DNA the sense and the antisence strand serve as templates.
- only the sense strand is used for bisulfite modified DNA as a template because the antisense strand (contains cytosines) is not available for the amplification reaction after the bisulfite modification. That is why there is a theoretical loss of one Ct value for bisulfite-modified DNA, since the template is halved after the bisulfite modification.
- the sequence of the primers and the Taq-man probe are as follows.
- Taq-man probe 5'- F AM- ATGGATG AAGAAAGAAAGGATG AGT-BHQ- 1 -3 '
- Step 1 Denaturation 95 ° C / 120 "
- Step 2 amplification 40 cycles (95 ° C / 4 "; 52 ° C / 40")
- FIG. 5 shows a real-time PCR from the CFF-1 assay. (magenta curves: No.
- a CFP 415 bp assay (cytosine-ffee primer binding site) with bisulfite-modified DNA was carried out as a further analysis. Since this assay is used to amplify long DNA sequences, this assay provides information about the degraded DNA during the bisulfite modification and during the refinement of bisulfite-modified DNA.
- the sequences from the primers are as follows: Forward primers: 5 ATGGGT AAGGAT ATG AAGTT AAT-3 '
- Reverse primer 50 pmol / m ⁇ : 0.1 m ⁇
- Step 1 Denaturation 95 ° C / 120 "
- Step 2 Amplification 40 cycles (95 ° C / 4 "; 58 ° C / 40")
- FIG. 6 shows a real-time PCR of the CFP 415 bp assay. (magenta curves: No Template Control, green and yellow curves: samples DNA after
- Exemplary embodiment 3 Manual bisulfite modification using paramagnetic
- the chemicals used for the bisulfite modification of the nucleic acids were partly taken from the commercial extraction kit innuCONVERT Bisulfite Basic Kit; Analytik Jena AG taken.
- the reaction mixture was transferred into the 2.0 ml reaction vessel with the plastic granules.
- 250 ml of 99.8% ethanol and 5 ml of Binding Optimizer (Analytik Jena AG) were added and the vessel was shaken for 10 minutes at room temperature and at 1400 rpm.
- the 2.0 ml reaction vessel was placed in a magnetic trap, the paramagnetic granules were separated and the supernatant was removed
- the 2.0 ml reaction vessel with the plastic granules was incubated at 65 ° C. for 10 minutes and 500 rpm with the lid open in order to remove the remaining alcohol.
- the bisulfite-modified DNA was detached from the plastic granulate according to the invention by adding elution buffer (innuCONVERT Bisulfite Basic Kit; Analytik Jena AG). For this, 100 ml of elution buffer were added to the plastic granules and the reaction vessel was incubated for 10 minutes at 65 ° C. and at 500 rpm.
- elution buffer innuCONVERT Bisulfite Basic Kit
- the 2.0 ml reaction vessel with the plastic granules was placed in a magnetic trap, the granules were separated and the eluate was transferred to a new 2.0 reaction vessel.
- the Spin Filter column-based extraction kit from Stiatec (InviGene Bisulfite Conversion Kit) was used for comparison. The instructions as described in the kit manual were followed exactly. After bisulfite modification reactions had been carried out, successful bisulfite modification was detected using various real-time PCR assays.
- a real-time PCR assay specific for the actin beta gene locus was used to quantify the total amount of bisulfite-modified DNA.
- the Actin Beta gene locus does not contain any CpG sites, therefore, after the bisulfite modification reaction, all cytosines from this gene locus are converted into uracils and these are detected as thymines in a real-time PCR assay. This assay was used to check whether the genomic DNA was bisulfite-modified.
- Taq-man probe 5'-F AM-ACCACCACCCAACACACAATAACAAACACA-BHQ- 1 -3 '
- Reverse primer 50 pmol / m ⁇ : 0.1 m ⁇
- Taq-man probe (25 pmol / m ⁇ ): 0.1 m ⁇
- the real-time PCR was carried out in the CFX96 real-time system from Biorad.
- Step 1 Denaturation 95 ° C / 120 "
- Step 2 amplification 40 cycles (95 ° C / 4 "; 57 ° C / 40")
- FIG. 7 shows a real-time PCR from the ⁇ -actin assay.
- genomic DNA magenta curves: No Template Control; red and green curve samples DNA after the respective bisulfite modification reaction). The results show that the genomic DNA could be successfully modified with the aid of the manual method of the invention.
- the cytosine free fragment (CFF-1) assay amplifies genomic and bisulfite-modified DNA with the same efficiency and is therefore suitable for quantifying the yield of bisulfite-modified DNA. It enables the direct comparison of input DNA and output DNA of the bisulite modification reaction.
- genomic DNA the sense and the antisence strand serve as templates.
- the antisense strand serves as a template in bisulfite-modified DNA, because the antisense strand (contains cytosines) is not available for the amplification reaction after the bisulfite modification.
- primers and the Taq-man probes are as follows: Forward primer: 5 '-T AAG AGT AAT AATGGATGG ATG ATG-3'
- Taq-man probe 5'-F AM-ATGGATGAAGAAAGAAAGGATGAGT-BHQ- 1 -3 'Real-time PCR approach:
- Step 1 Denaturation 95 ° C / 120 "
- Step 2 amplification 40 cycles (95 ° C / 4 "; 52 ° C / 40")
- FIG. 8 shows a real-time PCR from the CFF-1 assay.
- magenta curves No Template Control
- gray curves genomic DNA
- red and green curves sample DNA after bisulfite modification reaction.
- a CFP 415 bp assay cytosine-ffee primer binding site
- this assay provides information about the degraded DNA during the bisulfite modification and during the purification of bisulfite-modified DNA.
- the sequences from the primers are as follows:
- Reverse primer 50 pmol / m ⁇ : 0.1 m ⁇
- Step 1 Denaturation 95 ° C / 120 "
- Step 2 Amplification 40 cycles (95 ° C / 4 "; 58 ° C / 40")
- FIG. 9 shows a real-time PCR of the CFP 415 bp assay. (magenta curves: No Template Control, red and green curves: samples DNA after
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102019118332.4A DE102019118332B4 (de) | 2019-07-07 | 2019-07-07 | Verfahren und testkit zur bisulfitmodifizierung von dna |
| PCT/EP2020/069148 WO2021013534A1 (de) | 2019-07-07 | 2020-07-07 | Verfahren und testkit zur bisulfitmodifizierung von dna |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP3994277A1 true EP3994277A1 (de) | 2022-05-11 |
Family
ID=71944088
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP20750595.9A Withdrawn EP3994277A1 (de) | 2019-07-07 | 2020-07-07 | Verfahren und testkit zur bisulfitmodifizierung von dna |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP3994277A1 (de) |
| DE (1) | DE102019118332B4 (de) |
| WO (1) | WO2021013534A1 (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102021130283B4 (de) | 2021-11-19 | 2024-03-21 | Ist Innuscreen Gmbh | Verfahren und testkit zur preiswerten und ressourcensparenden extraktion von nukleinsäuren |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US182731A (en) | 1876-09-26 | Improvement in dies for forming horseshoes | ||
| US8076063B2 (en) * | 2000-02-07 | 2011-12-13 | Illumina, Inc. | Multiplexed methylation detection methods |
| DE10029915B4 (de) | 2000-06-19 | 2005-06-16 | Epigenomics Ag | Verfahren zum Nachweis von Cytosin-Methylierungen |
| US20060134643A1 (en) | 2000-06-19 | 2006-06-22 | Kurt Berlin | Bisulfite conversion of DNA |
| US9394332B2 (en) | 2002-08-29 | 2016-07-19 | Epigenomics Ag | Method for bisulfite treatment |
| CN1230531C (zh) * | 2002-12-09 | 2005-12-07 | 清华大学 | 从样品中分离细胞粒子的方法 |
| ES2787454T3 (es) * | 2004-09-30 | 2020-10-16 | Epigenomics Ag | Método para proveer fragmentos de ADN derivados de una muestra archivada |
| DE102010031401A1 (de) * | 2010-07-15 | 2012-01-19 | Aj Innuscreen Gmbh | Verfahren zur Anreicherung von Bakterien, Viren sowie Zellen und zur nachfolgenden Nukleinsäureisolierung |
| US9315853B2 (en) * | 2012-01-30 | 2016-04-19 | Exact Sciences Corporation | Modification of DNA on magnetic beads |
| PL3286325T3 (pl) | 2015-04-23 | 2023-01-23 | Ist Innuscreen Gmbh | Sposób i zestaw testowy do izolowania kwasów nukleinowych za pomocą szorstkich powierzchni |
| DE102017204267B4 (de) * | 2017-03-14 | 2021-05-27 | Aj Innuscreen Gmbh | Verfahren zur anreicherung von zellen aus einer probe und der nachfolgenden nukleinsäureisolierung aus diesen zellen |
-
2019
- 2019-07-07 DE DE102019118332.4A patent/DE102019118332B4/de not_active Expired - Fee Related
-
2020
- 2020-07-07 EP EP20750595.9A patent/EP3994277A1/de not_active Withdrawn
- 2020-07-07 WO PCT/EP2020/069148 patent/WO2021013534A1/de not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| DE102019118332A1 (de) | 2021-01-07 |
| WO2021013534A1 (de) | 2021-01-28 |
| DE102019118332B4 (de) | 2022-04-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60316642T2 (de) | Verbessertes Verfahren zur Bisulfit-Behandlung | |
| DE69836587T2 (de) | Nukleinsäuresammlung | |
| DE69733958T2 (de) | Verfahren zur positionierung von klonen mittels molekularen kaemmens | |
| EP1121460A1 (de) | Verfahren und mittel zur isolierung und reinigung von nukleinsäuren an oberflächen | |
| DE60015148T2 (de) | Simultane isolierung und quantifizierung von dna | |
| EP3286312B1 (de) | Vorrichtung und verfahren zur extraktion von nukleinsäuren | |
| EP2501811A1 (de) | Verfahren zur selektiven anreicherung und isolierung mikrobieller und optional zusätzlich viraler nukleinsäuren | |
| EP1851313B1 (de) | Verfahren zur isolierung von nukleinsäuren, wobei die nukleinsäuren bei erhöhter temperatur an einer matrix immobilisiert werden | |
| DE19512369A1 (de) | Vorrichtung zur Isolierung von Nukleinsäuren | |
| WO2010066554A1 (de) | Verfahren zur aufreinigung von nukleinsäuren, insbesondere aus fixiertem gewebe | |
| DE102008029356A1 (de) | Verfahren zur Aufreinigung von Nukleinsäuren, insbesondere aus fixiertem Gewebe | |
| EP1894214B1 (de) | Magnetpartikel mit einer geschlossenen, ultradünnen silikaschicht, verfahren zu deren herstellung und verwendung | |
| DE102008055120A1 (de) | Präparation und Amplifikation von Nukleinsäuren mittels magnetischer Partikel | |
| DE102017204267A1 (de) | Verfahren zur anreicherung von zellen aus einer probe und der nachfolgenden nukleinsäureisolierung aus diesen zellen | |
| EP2446054B1 (de) | Verfahren zur amplifikation von dna unter verwendung von tetraethylenglykol | |
| DE102014118532A1 (de) | Vorrichtung mit einer Filterschicht und Verfahren zur Gewinnung von Nukleinsäuren aus Formalin-fixierten und in Paraffin eingebetteten Proben | |
| DE102019118332B4 (de) | Verfahren und testkit zur bisulfitmodifizierung von dna | |
| DE102008013715B4 (de) | Verfahren zur DNA-Analyse | |
| DE10033991A1 (de) | Verfahren zur Isolierung von Nukleinsäuren | |
| DE102010043015B4 (de) | Verfahren zur Konzentration von Probenbestandteilen und Amplifikation von Nukleinsäuren | |
| EP3064944B1 (de) | Überschichtung zur partikelabtrennung | |
| EP2471955B1 (de) | Organismusspezifisches hybridisierbares Nucleinsäuremolekül | |
| DE10013847A1 (de) | Oligonukleotide oder PNA-Oligomere und Verfahren zur parallelen Detektion des Methylierungszustandes genomischer DNA | |
| DE102004045332B3 (de) | Verfahren zur Isolierung und Trennung von einzel- und doppelsträngigen Nucleinsäuren aus einer diese Nucleinsäuren enthaltenden Probe sowie Trennsäule zur Durchführung dieses Verfahrens | |
| DE10021204A1 (de) | Verfahren zur hochparallelen Analyse von Polymorphismen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: UNKNOWN |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
| 17P | Request for examination filed |
Effective date: 20220207 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| DAV | Request for validation of the european patent (deleted) | ||
| DAX | Request for extension of the european patent (deleted) | ||
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 20230103 |